Brief: Equillium Acquires Bioniz Therapeutics

Equillium

16/02/2022 14:42

Feb 16 (Reuters) - Equillium Inc  EQ.O :
    * EQUILLIUM ACQUIRES BIONIZ THERAPEUTICS SIGNIFICANTLY
EXPANDING
PIPELINE OF NOVEL IMMUNOMODULATORY DRUG CANDIDATES
    * EQUILLIUM INC - ACQUISITION INCLUDES TWO FIRST-IN-CLASS
CLINICAL-STAGE ASSETS AND PROPRIETARY PRODUCT DISCOVERY PLATFORM
    * EQUILLIUM INC - CLOSING CONSIDERATION OF 5,699,492 SHARES
OF
COMMON STOCK OF EQUILLIUM
    * EQUILLIUM INC - APPROXIMATELY 97% OF ISSUED EQUILLIUM
STOCK IS
SUBJECT TO A STANDARD 6-MONTH LOCK-UP PROVISION

Source text for Eikon:  ID:nBw7nx7vga 
Further company coverage:  EQ.O 

 ((reuters.briefs@thomsonreuters.com;))